Researchers observed a significant reduction in ACE2 activity in the mid-frontal cortex of AD patients and this reduction was inversely correlated with total β-amyloid and tau load as well as ACE activity (Kehoe et al., 2016). The gene discussed is MAPT; the disease is Alzheimer disease.